Top news of the week: 21.01.2021.
Startups
Lilly gives $60M to Merus, ties in $1.6B in biobucks for next-gen cancer research pact
Eli Lilly, via its Loxo Oncology biotech unit, is signing up to a three-therapy deal with Merus focused on T-cell redirecting bispecific antibody work.
Dana-Farber launches venture fund targeting incurable cancers
Binney Street Capital plans to invest in eight to 10 companies over the next three years. Developing new drugs will be a core focus, though investments could also go toward health services, ...
The crash landing of 'Operation Warp Speed'
Born as a second Manhattan Project, the Trump administration vaccine program actually achieved most of its goals – until distribution problems marred its success.
Mark Cuban Is Going To Help Big Pharma’s Image
Cuban is taking an important step in helping to realize Kolchinsky’s “Biotech Social Contract” – the deal that drug companies has with society in which innovative life-saving drugs have ...
Advancing The World Through Biotech With Dr. Michelle McMurry-Heath
The head of the Biotechnology Innovation Organization, or BIO, shares fascinating insights on battling Covid-19, exciting advances being made on other diseases and much else.
Beam, Verve stockpile cash as investors bank on gene editing progress
Beam expects to receive $260 million through a private stock placement, while Verve raised $94 million to support initial studies of its heart disease treatment.
Verve Therapeutics Secures $94 Million in Series B Financing to Advance Pipeline of Gene Editing Medicines for Cardiovascular Disease
Verve Therapeutics, a biotech company pioneering gene editing medicines to treat cardiovascular disease, today announced the successful completion of
India's vaccine diplomacy in South Asia pushes back against China
India will give millions of doses of COVID-19 vaccine to South Asian countries in the next few weeks, government sources said on Thursday, drawing praise from its neighbours and pushing ...